» Research Continuity

Chapman is rapidly responding to the changing COVID-19 pandemic throughout it’s many units and services. All activities of the Office of Research continue and any changes in operations will be communicated here and on the Chapman Coronavirus website. The State of California, as outlined in the Resilience Roadmap Stages, and OC Health Care Agency are lifting restrictions in many sectors of the economy. The following provides guidance for development of plans for restart and ramp up of research, scholarly and creative activities at Chapman. The framework for a restarting research and creative activities is based on the following resources:

As part of the CU Safely Back Plan, Chapman is proposing mitigation strategies of Physical Distancing, Symptoms Monitoring, Public Health Interventions, Face Coverings, Sanitation, and Return to Earlier Phase which are all important aspects of this plan for restarting research and creative activities. Below is information to inform faculty members, independent researchers and Unit leadership the guidance and process for restarting research.

The initial phase of the plan to transition from Phase 1 (current phase) to Phase 2 which will allow for a limited expansion of research activities will take place on June 22nd

Toggle Section

Additional Questions

For any questions not covered on this website for Research Continuity, please visit the FAQs for Research Continuity. Also, feel free to reach out to the contacts below or the Office of Research at (officeofresearch@chapman.edu)

Tom Piechota, Vice President for Research, piechota@chapman.edu, 714-628-2897

Jill Borland, Director of Sponsored Projects Service, jborland@chapman.edu, 714-628-7383

Michael Briggs, Director of Research Integrity, mibriggs@chapman.edu, 714-628-7201

Lawrence Lau, Director of Industry Alliance and Commercialization, lalau@chapman.edu, 714-628-2875